Anthropic launched a science research platform AND announced its own drug programs on the same day. The toolmaker opened a mine next to its customers’ mines.
Claude Science connects 60-plus scientific databases, runs code on HPC clusters, and keeps data on your own infrastructure. Reproducibility is baked in, every result traces to source code.
The conflict: Anthropic sells to pharma and also runs its own preclinical programs. Official answer is they only chase neglected diseases. Disease interest is not static, and that boundary is softer than it sounds.
BCG data on AI-discovered molecules: Phase 1 safety jumped to 80-90%. Phase 2 efficacy stayed flat at 40%. The field finds safer drugs. It has not yet found drugs that work at scale.
Subscribe to www.onhealthcare.tech for free and paid articles, podcasts, and more.
